Biotech Beneficiaries of the Legal Cannabis Movement

The biotech sector differs from other sectors of the market in the sense that it is the only industry where earnings are not the most important event for companies.

Unlike other sectors, the biotech sector trades on FDA results, not earnings; and favorable results can serve as a major catalyst for the company and send the price of the company’s stock considerably higher.

Biotech Beneficiaries

The biotech sector will be one of the greatest beneficiaries of the legal cannabis movement and there are only a few publicly traded biotech companies that are focused on developing treatments from the cannabis plan.

One such company is AXIM Biotechnologies (AXIM) and we are monitoring the company closely after it recently saw a significant increase it trading volume.  

Last week, we heard AXIM CEO George E. Anastassov, MD, DDS, MBA, speak at the The MoneyShow Dallas about the value of cannabinoids and...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.